Early research (Phase 1)Study completedNCT00735306What this trial is testingPhase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Duke University 12
Not applicableEnded earlyNCT00896467What this trial is testingPsychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyWho this might be right forAnal CancerAnxiety DisorderBreast Cancer+9 more Centre Oscar Lambret 200
Not applicableStudy completedNCT02400398What this trial is testingEvaluating Weight Stability of Pancreatic Cancer Cachexia PatientsWho this might be right forPancreatic NeoplasmsPancreatic CancerCachexia+1 more Andrew Hendifar, MD 30
Early research (Phase 1)Study completedNCT00565487What this trial is testingCombination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Milton S. Hershey Medical Center 15
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)UnknownNCT04000906What this trial is testingPIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisWho this might be right forPeritoneal Carcinomatosis University Hospital, Geneva 18
Early research (Phase 1)Study completedNCT02262455What this trial is testingEffects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsWho this might be right forOvarian CancerFallopian Tube CancerEndometrial Cancer+1 more Santa Maria Biotherapeutics 32
Testing effectiveness (Phase 2)Study completedNCT00238199What this trial is testingCalcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)Looking for participantsNCT07435038What this trial is testingStudy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASWho this might be right forNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Betta Pharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821284What this trial is testingSonoporation and Chemotherapy for the Treatment of Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more Flemming Forsberg 120
Testing effectiveness (Phase 2)UnknownNCT02294006What this trial is testingActivity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsWho this might be right forWell Differentiated Pancreatic Endocrine Tumor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 20
Early research (Phase 1)Ended earlyNCT01198522What this trial is testingCombination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer PatientsWho this might be right forPancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection Philogen S.p.A. 28
Testing effectiveness (Phase 2)UnknownNCT05143151What this trial is testingCD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic CancerWho this might be right forAdvanced Pancreatic Carcinoma Shenzhen University General Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT02117479What this trial is testingStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Who this might be right forPancreatic Cancer Incyte Corporation 321
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Early research (Phase 1)Ended earlyNCT00281996What this trial is testingImatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic CancerWho this might be right forPancreatic Cancer Northwestern University 19
Testing effectiveness (Phase 2)Ended earlyNCT02331251What this trial is testingStudy of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Who this might be right forAdvanced CancerBreast CancerSarcoma+3 more Western Regional Medical Center 81
Not applicableActive Not RecruitingNCT03704662What this trial is testingPreoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Medical College of Wisconsin 102
Testing effectiveness (Phase 2)Looking for participantsNCT07306273What this trial is testingIRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG TherapyWho this might be right forPancreatic Adenocarcinoma Locally Advanced Ruijin Hospital 20